Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)First in Human Study in Healthy Volunteers of Antimicrobial Peptide PL-18 Vaginal Suppositories
Phase 1
Recruiting
- Conditions
- ColpomycosisBacterial VaginosisMixede Vaginitis
- Interventions
- Drug: Dose 1 to 5 of Antimicrobial Peptide PL-18 Vaginal SuppositoriesDrug: Placebo dose 1 to 5 of Antimicrobial Peptide PL-18 Vaginal Suppositories
- First Posted Date
- 2022-04-22
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- Protelight Pharmaceuticals Australia PTY LTD
- Target Recruit Count
- 50
- Registration Number
- NCT05340790
- Locations
- 🇦🇺
Q-Pharm Pty. Ltd, Brisbane, Queensland, Australia
News
No news found